TY - JOUR
T1 - Whole genome sequencing and antimicrobial resistance of staphylococcus aureus from surgical site infections in Ghana
AU - Egyir, Beverly
AU - Bentum, Jeannette
AU - Attram, Naiki
AU - Fox, Anne
AU - Obeng-Nkrumah, Noah
AU - Appiah-Korang, Labi
AU - Behene, Eric
AU - Kumordjie, Selassie
AU - Yeboah, Clara
AU - Agbodzi, Bright
AU - Bentil, Ronald Essah
AU - Tagoe, Rhodalyn
AU - Tabi, Blessing Kofi Adu
AU - Owusu, Felicia
AU - Dayie, Nicholas T.K.D.
AU - Donkor, Eric S.
AU - Nsaful, Josephine
AU - Asah-Opoku, Kwaku
AU - Nyarko, Edward
AU - Asumanu, Edward
AU - Larsen, Anders Rhod
AU - Wolfe, David M.
AU - Letizia, Andrew G.
N1 - Publisher Copyright:
© 2021 by the author. Licensee MDPI, Basel, Switzerland.
PY - 2021/2
Y1 - 2021/2
N2 - Staphylococcus aureus (S. aureus) is a common cause of surgical site infections (SSIs) globally. Data on the occurrence of methicillin-susceptible S. aureus (MSSA) as well as methicillin-resistant S. aureus (MRSA) among patients with surgical site infections (SSIs) in sub-Saharan African are scarce. We characterized S. aureus from SSIs in Ghana using molecular methods and antimicrobial susceptibility testing (AST). Wound swabs or aspirate samples were collected from subjects with SSIs. S. aureus was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS); AST was performed by Kirby-Bauer disk diffusion, and results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guideline. Detection of spa, mecA, and pvl genes was performed by polymerase chain reaction (PCR). Whole-genome sequencing (WGS) was done using the Illumina MiSeq platform. Samples were collected from 112 subjects, with 13 S. aureus isolates recovered. Of these, 92% were sensitive to co-trimoxazole, 77% to clindamycin, and 54% to erythromycin. Multi-drug resistance was detected in 5 (38%) isolates. The four mecA gene-positive MRSA isolates detected belonged to ST152 (n = 3) and ST5 (n = 1). In total, 62% of the isolates were positive for the Panton-Valentine leukocidin (pvl) toxin gene. This study reports, for the first time, a pvl-positive ST152-t355 MRSA clone from SSIs in Ghana. The occurrence of multi-drug-resistant S. aureus epidemic clones suggests that continuous surveillance is required to monitor the spread and resistance trends of S. aureus in hospital settings in the country.
AB - Staphylococcus aureus (S. aureus) is a common cause of surgical site infections (SSIs) globally. Data on the occurrence of methicillin-susceptible S. aureus (MSSA) as well as methicillin-resistant S. aureus (MRSA) among patients with surgical site infections (SSIs) in sub-Saharan African are scarce. We characterized S. aureus from SSIs in Ghana using molecular methods and antimicrobial susceptibility testing (AST). Wound swabs or aspirate samples were collected from subjects with SSIs. S. aureus was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS); AST was performed by Kirby-Bauer disk diffusion, and results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guideline. Detection of spa, mecA, and pvl genes was performed by polymerase chain reaction (PCR). Whole-genome sequencing (WGS) was done using the Illumina MiSeq platform. Samples were collected from 112 subjects, with 13 S. aureus isolates recovered. Of these, 92% were sensitive to co-trimoxazole, 77% to clindamycin, and 54% to erythromycin. Multi-drug resistance was detected in 5 (38%) isolates. The four mecA gene-positive MRSA isolates detected belonged to ST152 (n = 3) and ST5 (n = 1). In total, 62% of the isolates were positive for the Panton-Valentine leukocidin (pvl) toxin gene. This study reports, for the first time, a pvl-positive ST152-t355 MRSA clone from SSIs in Ghana. The occurrence of multi-drug-resistant S. aureus epidemic clones suggests that continuous surveillance is required to monitor the spread and resistance trends of S. aureus in hospital settings in the country.
KW - Africa
KW - Mrsa
KW - Surgical site infections
KW - Whole-genome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85101581034&partnerID=8YFLogxK
U2 - 10.3390/pathogens10020196
DO - 10.3390/pathogens10020196
M3 - Article
AN - SCOPUS:85101581034
SN - 2076-0817
VL - 10
SP - 1
EP - 13
JO - Pathogens
JF - Pathogens
IS - 2
M1 - 196
ER -